Medicinal Chemistry Driven Approaches Toward Novel and Selective Serotonin 5-HT6Receptor Ligands

Journal of Medicinal Chemistry
2005.0

Abstract

Based on a medicinal chemistry guided hypothetical pharmacophore model, novel series of indolyl sulfonamides have been designed and prepared as selective and high-affinity serotonin 5-HT(6) receptor ligands. Furthermore, based on a screening approach of a discovery library, a series of benzoxazinepiperidinyl sulfonamides were identified as selective 5-HT(6) ligands. Many of the compounds described in this paper possess excellent affinities, displaying pK(i) values greater than 8 (some even >9) and high selectivities against a wide range (>50) of other CNS relevant receptors. First, structure-affinity relationships of these ligands are discussed. In terms of functionality, high-affinity antagonists, as well as agonists and even partial agonists, were prepared. Compounds 19c and 19g represent the highest-affinity 5-HT(6) agonists ever reported in the literature. These valuable tool compounds should allow for the detailed study of the role of the 5-HT(6) receptor in relevant animal models of disorders such as cognition deficits, depression, anxiety, or obesity.

Knowledge Graph

Similar Paper

Medicinal Chemistry Driven Approaches Toward Novel and Selective Serotonin 5-HT<sub>6</sub>Receptor Ligands
Journal of Medicinal Chemistry 2005.0
5-Cyclic Amine-3-arylsulfonylindazoles as Novel 5-HT<sub>6</sub> Receptor Antagonists
Journal of Medicinal Chemistry 2010.0
Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT6
European Journal of Medicinal Chemistry 2019.0
2-Aminoimidazole-based antagonists of the 5-HT6 receptor – A new concept in aminergic GPCR ligand design
European Journal of Medicinal Chemistry 2019.0
2-Substituted Tryptamines:  Agents with Selectivity for 5-HT<sub>6</sub>Serotonin Receptors
Journal of Medicinal Chemistry 2000.0
Synthesis of New Arylpiperazinylalkylthiobenzimidazole, Benzothiazole, or Benzoxazole Derivatives as Potent and Selective 5-HT<sub>1A</sub> Serotonin Receptor Ligands
Journal of Medicinal Chemistry 2008.0
Novel Aza-analogous Ergoline Derived Scaffolds as Potent Serotonin 5-HT<sub>6</sub> and Dopamine D<sub>2</sub> Receptor Ligands.
Journal of Medicinal Chemistry 2014.0
Synthesis of New Serotonin 5-HT<sub>7</sub>Receptor Ligands. Determinants of 5-HT<sub>7</sub>/5-HT<sub>1A</sub>Receptor Selectivity
Journal of Medicinal Chemistry 2009.0
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties
European Journal of Medicinal Chemistry 2020.0
Structure–activity relationships and molecular modeling studies of novel arylpiperazinylalkyl 2-benzoxazolones and 2-benzothiazolones as 5-HT7 and 5-HT1A receptor ligands
European Journal of Medicinal Chemistry 2014.0